WZ4003

WZ4003

Cat. No.: DIA-0230043

Size: 50 mg Size: 500 mg Size: Customer Size
Product Information
CAS No. 1214265-58-3
Formula C25H29ClN6O3
Molecular Weight 496.99
SMILES CCC(=O)NC1=CC=CC(=C1)OC2=NC(=NC=C2Cl)NC3=C(OC)C=C(C=C3)N4CCN(C)CC4
Product Description WZ4003 is a highly specific NUAK kinase inhibitor with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2 in cell-base assays, respectively, without significant inhibition on 139 other kinases.
Format & Storage
Purity > 98%
Shipping Shipped on dry ice.
Storage Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month
Solubility Overview Soluble in DMSO
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top